Table II.
Target lesion specification
| Parameter | Value |
|---|---|
| Target vessel (N = 55) | |
| LAD, n (%) | 15 (31.5) |
| LCX, n (%) | 13 (24.6) |
| RCA, n (%) | 18 (34.2) |
| LM, n (%) | 8 (8.2) |
| SCV, n (%) | 1 (1.3) |
| Lesion types (AHA)* (N = 73) | |
| A1, n (%) | 0 |
| B1, n (%) | 3 (4.1) |
| B2, n (%) | 4 (5.5) |
| C, n (%) | 90.4 (65) |
| Calcification, n (%) | 68 (93.1) |
| Ostial, n (%) | 29 (39.7) |
| CTO, n (%) | 7 (9.58) |
| Tortuous, n (%) | 45 (73.61) |
| ISR, n (%) | 73 (100) |
| DES-ISR, n (%) | 6 (84.7) |
| BMS-ISR, n (%) | 12 (16.1) |
*
American Heart Association. LAD – left anterior descending artery, LCX – left circumflex artery, RCA – right coronary artery, LM – left main trunk, SVG – saphenous vein graft, ISR – in-stent restenosis, CTO-chronic total occlusion, DES – drug eluting stent, BMS – bare metal stent.